Skip to content
The Big India

The Big India

Primary Menu
  • Business
  • Education
  • Entertainment
  • Finance
  • Lifestyle
  • National
  • Press Release
  • Technology
  • Home
  • 2022
  • August
  • 18
  • JFL Life Sciences Limited files Prospectus with NSE EMERGE
  • Business
  • Business News
  • Press Release

JFL Life Sciences Limited files Prospectus with NSE EMERGE

August 18, 2022

New Delhi (India), August 18: JFL Life Sciences Limited, engaged in the business of manufacturing pharmaceutical products having an experience for more than a decade, has filed the prospectus with NSE EMERGE to raise Rs 1,816.58 Lakhs through an initial public offering (IPO).

The public issue of JFL Life Sciences Limited is for 29,78,000 equity shares of Face Value ₹10 each (“EQUITY SHARES”) for cash at a price of ₹ 61/- per equity share (including a securities premium of ₹ 51/- per equity share) (the issue price) aggregating ₹ 1,816.58 LACS of the issue. 1,50,000 equity shares aggregating to ₹ 91.50 Lakhs will be reserved for market maker (“Market Maker Reservation Portion”). The issue, less the Market Maker Reservation Portion, i.e., issue of 28,28,000 equity shares of Face Value of ₹ 10/- EACH at an issue price of ₹ 61/- per equity share, aggregating to ₹ 1,725.08 Lakhs, which is hereinafter referred to as “The Net Issue”. The issue and the Net Issue will constitute 27.08% AND 25.71%, respectively of the post issue paid up equity share capital of the company. The company will list at NSE Emerge. The Lead manager of the issue is GYR Capital Advisors Pvt Ltd and the Registrar to the issue is KFin Technologies Ltd.

The company intends to utilize the proceeds of the Issue to meet the following objectives:

  1. Repayment of secured and unsecured loans
  2. Funding the working capital requirements of the company
  3. General Corporate Purposes

JFL Life Sciences Limited is engaged in the business of manufacturing pharmaceutical products. Their product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).With market presence in pan India, products of JFL supplies to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and an FDA approved state of the art manufacturing facility near Ahmedabad.

The Company has registered their products to manufacture in various countries like sovereign of Kenya, Nigeria, Yemen, & Myanmar. Few of their products are also registered with Ukraine, Uzbekistan, and Kazakhstan as well. This builds a moat around their business. This also makes them a ‘one-stop-shop’ service provider for catering to all of the customer’s needs domestically as well as internationally.

The promoters, Mr. Smiral Ashwinbhai Patel and Tejal Smiralbhai Patel are actively involved in the day-to-day business of the company and are the guiding force behind the strategic decisions for the Company. Their management team and other key management personnel are well qualified and have extensive industry expertise, and have been responsible for the operational growth.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

About the Author

View All Posts

Continue Reading

Previous: Gujarat based Rhetan TMT’s Rs. 56 crore public issue on BSE SME platform opens for subscription on August 22
Next: Start your medical studies in India without NEET; applications are still open for St. George’s University (SGU) in association with the Ramaiah Group of Institutions

Related Stories

1-6.jpg
  • Business

Era of AI-driven jewellery design begins: ISGJ launches New GenZ campus in Surat

Vikas Dubey November 8, 2025
Zam-Zam.jpg
  • Business

Zam Zam Perfumers Redefines Indian Luxury with “The Elysian Collection” — Fragrance Stories of Heritage and Sophistication

Vikas Dubey November 8, 2025
PNN-2025-11-08T115032.007.jpg
  • Business

Patel Retail Gets Technical Boost From Anand Rathi, Sees 14% Upside For Stock Price

Vikas Dubey November 8, 2025

Recent Posts

  • The Rise of Eco-Luxury: Why Sustainable Interiors Are the New Obsession
  • Bengaluru to Host Children’s Health Festival and Childhood Obesity Conference on November 15
  • A Night of Glitz, Grace, and Gratitude: Dr. Shivani Mayekar Rao’s OTT-Themed Birthday Bash Dazzles Mumbai
  • ‘O Janeja’ — Krishna Gautam and Freddy Daruwala’s Chemistry Wins Audiences Over
  • Era of AI-driven jewellery design begins: ISGJ launches New GenZ campus in Surat

You may have missed

PNN-2025-11-08T185558.046.jpg
  • Lifestyle

The Rise of Eco-Luxury: Why Sustainable Interiors Are the New Obsession

Vikas Dubey November 8, 2025
nov.jpg
  • Health

Bengaluru to Host Children’s Health Festival and Childhood Obesity Conference on November 15

Vikas Dubey November 8, 2025
PNN-21.jpg
  • Lifestyle

A Night of Glitz, Grace, and Gratitude: Dr. Shivani Mayekar Rao’s OTT-Themed Birthday Bash Dazzles Mumbai

Vikas Dubey November 8, 2025
PNN-2025-11-08T155220.796.jpg
  • Entertainment

‘O Janeja’ — Krishna Gautam and Freddy Daruwala’s Chemistry Wins Audiences Over

Vikas Dubey November 8, 2025
  • Business
  • Education
  • Entertainment
  • Finance
  • Lifestyle
  • National
  • Press Release
  • Technology
Copyright © All rights reserved. | MoreNews by AF themes.